HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ewelina Piktel Selected Research

ceragenin CSA-131

10/2021Peanut-Shaped Gold Nanoparticles with Shells of Ceragenin CSA-131 Display the Ability to Inhibit Ovarian Cancer Growth In Vitro and in a Tumor Xenograft Model.
1/2020Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ewelina Piktel Research Topics

Disease

13Infections
07/2022 - 10/2015
11Neoplasms (Cancer)
07/2022 - 01/2015
7Inflammation (Inflammations)
07/2022 - 03/2017
3Colonic Neoplasms (Colon Cancer)
01/2020 - 01/2015
2COVID-19
01/2022 - 03/2021
2Breast Neoplasms (Breast Cancer)
01/2022 - 04/2018
2Ovarian Neoplasms (Ovarian Cancer)
10/2021 - 01/2021
2Mycoses (Diseases, Fungus)
12/2020 - 01/2016
2Bacterial Infections (Bacterial Infection)
02/2019 - 01/2018
2Carcinogenesis
04/2018 - 02/2016
1Urinary Bladder Neoplasms (Bladder Cancer)
07/2022
1Pancreatitis
01/2022
1Cystic Fibrosis (Mucoviscidosis)
01/2022
1Otitis Media
12/2021
1Leukoplakia
07/2021
1Cross Infection (Nosocomial Infection)
01/2021
1Ovarian Epithelial Carcinoma
01/2021
1Sepsis (Septicemia)
04/2020
1Multiple Myeloma
11/2019
1Urinary Tract Infections (Urinary Tract Infection)
05/2019
1Gaucher Disease (Gaucher's Disease)
02/2019
1Hematologic Neoplasms (Hematological Malignancy)
02/2019
1Endotoxemia
02/2019
1Pathologic Processes
08/2018
1Suppuration
01/2018
1Communicable Diseases (Infectious Diseases)
01/2018
1Hyperthermia
08/2017
1Coinfection
07/2017
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2017
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
03/2017
1Periodontal Diseases (Periodontal Disease)
01/2017
1HIV Infections (HIV Infection)
01/2016

Drug/Important Bio-Agent (IBA)

8cerageninsIBA
12/2021 - 01/2016
6CathelicidinsIBA
07/2022 - 01/2015
6GelsolinIBA
01/2022 - 01/2018
6GoldIBA
01/2022 - 02/2019
5Anti-Bacterial Agents (Antibiotics)IBA
03/2021 - 01/2016
4Peptides (Polypeptides)IBA
05/2022 - 01/2015
4Antineoplastic Agents (Antineoplastics)IBA
10/2021 - 05/2016
4Pharmaceutical PreparationsIBA
12/2020 - 05/2016
3sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
07/2022 - 03/2017
3ceragenin CSA-13IBA
04/2018 - 01/2015
2EnzymesIBA
07/2022 - 11/2019
2LigandsIBA
01/2022 - 02/2016
2VimentinIBA
01/2022 - 03/2021
2AntibodiesIBA
01/2022 - 03/2021
2SARS-CoV-2 spike proteinIBA
01/2022 - 03/2021
2ceragenin CSA-131IBA
10/2021 - 01/2020
2Indicators and Reagents (Reagents)IBA
04/2020 - 08/2018
2ferric oxide (iron oxide)IBA
01/2020 - 02/2019
2Phosphatidylinositols (Phosphatidylinositol)IBA
07/2019 - 02/2019
2SphingolipidsIBA
02/2019 - 03/2017
1SphingosineIBA
07/2022
1sphingosine kinaseIBA
07/2022
1Adenylate KinaseIBA
01/2022
1Cysteine (L-Cysteine)FDA Link
01/2022
1Metformin (Glucophage)FDA LinkGeneric
01/2022
1resazurinIBA
01/2022
1Proline Oxidase (Proline Dehydrogenase)IBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021
1CollagenIBA
07/2021
1Deoxyglucose (2 Deoxy D glucose)IBA
04/2020
1Antimicrobial Cationic PeptidesIBA
12/2019
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
11/2019
1AcidsIBA
11/2019
1SolutionsIBA
05/2019
1CeramidesIBA
02/2019
1Blood Proteins (Serum Proteins)IBA
02/2019
1Actin Depolymerizing Factors (Cofilins)IBA
08/2018
1Antimicrobial PeptidesIBA
04/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Actins (F Actin)IBA
01/2018
1Deoxyribonucleases (DNase)FDA Link
01/2018
1Gentian Violet (Violet, Crystal)FDA Link
01/2018
1Aspartic Acid (Aspartate)FDA Link
01/2018

Therapy/Procedure

5Therapeutics
12/2020 - 05/2016
1Drug Therapy (Chemotherapy)
01/2021
1Precision Medicine
01/2015